GlassScriptPhysician profile
Hany J Jacob
NPI 1992786677
$6,291.53
in general payments reported to CMS, 2019-2025
36 companies · $1,129 in 2025
The $1,129 reported for 2025 was more than what 79% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,019 · 2020: $440 · 2021: $762 · 2022: $625 · 2023: $1,303 · 2024: $1,014 · 2025: $1,129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,366 · Education: $79.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,365.79 |
| Education | $79.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,156.14 | 2019-2025 | Breztri, Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $977.60 | 2019-2025 | Arexvy, Nucala, Trelegy Ellipta |
| United Therapeutics Corporation | $436.94 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $419.05 | 2020-2025 | Dupixent |
| Insmed, INC. | $375.62 | 2019-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $287.99 | 2019-2024 | Ofev |
| Actelion Pharmaceuticals US, INC. | $275.48 | 2019-2024 | Uptravi, Opsumit |
| Genzyme Corporation | $249.68 | 2019-2025 | |
| Harmony Biosciences LLC | $232.64 | 2020-2025 | Wakix |
| Mylan Specialty L.P. | $216.01 | 2021-2024 | Yupelri |
| Jazz Pharmaceuticals INC. | $204.21 | 2019-2025 | Xywav |
| Grifols USA, LLC | $182.07 | 2019-2025 | Prolastin-C Liquid |
| Sunovion Pharmaceuticals INC. | $168.98 | 2019-2020 | |
| Philips North America LLC | $165.19 | 2019-2023 | |
| Axsome Therapeutics, INC. | $164.56 | 2023 | Sunosi |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $127.19 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Amgen INC. | $115.37 | 2022-2025 | Tezspire |
| Abbvie INC. | $78.12 | 2021-2024 | |
| Pulmonx Corporation | $72.57 | 2021-2022 | |
| Electromed, INC. | $58.99 | 2019-2025 | Smartvest |
| Merck Sharp & Dohme LLC | $29.94 | 2021-2023 | |
| Gilead Sciences, INC. | $28.69 | 2019-2021 | |
| Avadel Cns Pharmaceuticals, LLC | $28.67 | 2024 | Lumryz |
| Takeda Pharmaceuticals U.S.A., INC. | $27.73 | 2022-2024 | Glassia |
| Genentech USA, INC. | $27.62 | 2019 | |
| Advanced Respiratory, INC | $27.59 | 2019 | |
| Fisher & Paykel Healthcare INC | $24.03 | 2024 | Fisher & Paykel Healthcare |
| Ani Pharmaceuticals, INC. | $21.15 | 2024 | Purified Cortrophin Gel |
| Resmed Corp | $18.45 | 2019 | |
| Mallinckrodt Hospital Products INC. | $17.26 | 2022 | |
| Viatris Specialty LLC | $14.71 | 2025 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $14.68 | 2020 | |
| Inspire Medical Systems, INC. | $13.43 | 2024 | Inspire |
| Astellas Pharma US INC | $11.13 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.11 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hany Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.